Suanfarma Suanfarma

X

CAS 943969-38-8 manufacturers and suppliers on PharmaCompass

PharmaCompass
CAS 943969-38-8
Also known as: 943969-38-8, Dtxsid901115497, Alpha1-[[[6-(4-phenylbutoxy)hexyl](phenylmethyl)amino]methyl]-4-(phenylmethoxy)-1,3-benzenedimethanol
Molecular Formula
C39H49NO4
Molecular Weight
595.8  g/mol
InChI Key
PSHAXLAATQLRBM-UHFFFAOYSA-N

1 2D Structure

CAS 943969-38-8

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
2-[benzyl-[6-(4-phenylbutoxy)hexyl]amino]-1-[3-(hydroxymethyl)-4-phenylmethoxyphenyl]ethanol
2.1.2 InChI
InChI=1S/C39H49NO4/c41-31-37-28-36(23-24-39(37)44-32-35-21-10-5-11-22-35)38(42)30-40(29-34-19-8-4-9-20-34)25-13-1-2-14-26-43-27-15-12-18-33-16-6-3-7-17-33/h3-11,16-17,19-24,28,38,41-42H,1-2,12-15,18,25-27,29-32H2
2.1.3 InChI Key
PSHAXLAATQLRBM-UHFFFAOYSA-N
2.1.4 Canonical SMILES
C1=CC=C(C=C1)CCCCOCCCCCCN(CC2=CC=CC=C2)CC(C3=CC(=C(C=C3)OCC4=CC=CC=C4)CO)O
2.2 Synonyms
2.2.1 Depositor-Supplied Synonyms

1. 943969-38-8

2. Dtxsid901115497

3. Alpha1-[[[6-(4-phenylbutoxy)hexyl](phenylmethyl)amino]methyl]-4-(phenylmethoxy)-1,3-benzenedimethanol

2.3 Create Date
2017-01-24
3 Chemical and Physical Properties
Molecular Weight 595.8 g/mol
Molecular Formula C39H49NO4
XLogP37.1
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count5
Rotatable Bond Count21
Exact Mass595.36615904 g/mol
Monoisotopic Mass595.36615904 g/mol
Topological Polar Surface Area62.2 Ų
Heavy Atom Count44
Formal Charge0
Complexity688
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count1
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
Flag Finland
Digital Content Digital Content
URL Supplier Web Content
89365-50-4
Salmeterol Xinafoate
Fermion is fully owned subsidiary of Orion Corporation & headquartered in Espoo, Finland. Together with O...
Fermion is fully owned subsidiary of Orion Corporation & headquartered in Espoo, Finland. Together with Orion we are a fully integrated CDMO & offer services covering both APIs & Formulations. API portfolio consists of >30 generic APIs & >10 NCEs & 2 mfg. sites as well as R&D facilities are all located in Finland. Fermion has invested & expanded capabilities in the production of HPAPIs. Drug product CMO services include hormonal & non-hormonal semi-solids, cytotoxic oral solids & packaging. We have 3 mfg. sites & one packaging center for drug products at Orion.
Flag Finland
Digital Content Digital Content
URL Supplier Web Content
163923-18-0
Salmeterol Xinafoate
Fermion is fully owned subsidiary of Orion Corporation & headquartered in Espoo, Finland. Together with O...
Fermion is fully owned subsidiary of Orion Corporation & headquartered in Espoo, Finland. Together with Orion we are a fully integrated CDMO & offer services covering both APIs & Formulations. API portfolio consists of >30 generic APIs & >10 NCEs & 2 mfg. sites as well as R&D facilities are all located in Finland. Fermion has invested & expanded capabilities in the production of HPAPIs. Drug product CMO services include hormonal & non-hormonal semi-solids, cytotoxic oral solids & packaging. We have 3 mfg. sites & one packaging center for drug products at Orion.
Flag India
Digital Content Digital Content
97664-55-6
Salmeterol Xinafoate
Vamsi Labs, established in 1991, is a leading Indian API manufacturer. Specializing in anti-asthmatic, an...
Vamsi Labs, established in 1991, is a leading Indian API manufacturer. Specializing in anti-asthmatic, anti-migraine & anti-psychotic APIs, it caters to domestic & international markets(50% sales). Anti-asthma products account for 60% of sales. Vamsi adheres to high corporate governance, transparency, professionalism, & environmental protection standards. It's USFDA approved & ISO 9001:2015, ISO 14001:2015, & ISO 45001:2018 certified. With a DSIR-certified R&D Lab, Vamsi continues to innovate & meet the pharma industry's evolving needs. Vamsi is poised to grow its globally while maintaining its commitment to excellence and sustainability.
Vamsi Labs

INS 2024

Not Confirmed

envelop Contact Supplier
Flag India
Digital Content Digital Content
27475-14-5
Salmeterol Xinafoate
Vamsi Labs, established in 1991, is a leading Indian API manufacturer. Specializing in anti-asthmatic, an...
Vamsi Labs, established in 1991, is a leading Indian API manufacturer. Specializing in anti-asthmatic, anti-migraine & anti-psychotic APIs, it caters to domestic & international markets(50% sales). Anti-asthma products account for 60% of sales. Vamsi adheres to high corporate governance, transparency, professionalism, & environmental protection standards. It's USFDA approved & ISO 9001:2015, ISO 14001:2015, & ISO 45001:2018 certified. With a DSIR-certified R&D Lab, Vamsi continues to innovate & meet the pharma industry's evolving needs. Vamsi is poised to grow its globally while maintaining its commitment to excellence and sustainability.
Vamsi Labs

INS 2024

Not Confirmed

envelop Contact Supplier
Flag India
Digital Content Digital Content

2-(N-(6-(4-phenylbutoxy)hexyl)-N-benzylamino)-1-(4-(ben...

URL Supplier Web Content
Salmeterol Xinafoate
Gangwal is a progressive and innovative business group with a clear vision and ascertaining new challenge...
Gangwal is a progressive and innovative business group with a clear vision and ascertaining new challenges, having a strong foundation supported by strong pillars of committed experts from all business functions . Gangwal was founded in 1987 with a clear Vision for providing innovative products and services for rapidly growing Pharmaceuticals, Nutraceuticals and Personal Care sectors in India. Envisaging the need of the pharma and nutraceutical sectors, Gangwal was first to introduce Cyclodextrins, concept of Carnitine, veg origin DHA, multi sweeteners concept like Sucralose, Neotame,Acesulfame K, Fructose and Lactitol etc. in India
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag India
Digital Content Digital Content

6-(4-phenylbutoxy)-N-benzylheane-1-amine

URL Supplier Web Content
Salmeterol Xinafoate
Gangwal is a progressive and innovative business group with a clear vision and ascertaining new challenge...
Gangwal is a progressive and innovative business group with a clear vision and ascertaining new challenges, having a strong foundation supported by strong pillars of committed experts from all business functions . Gangwal was founded in 1987 with a clear Vision for providing innovative products and services for rapidly growing Pharmaceuticals, Nutraceuticals and Personal Care sectors in India. Envisaging the need of the pharma and nutraceutical sectors, Gangwal was first to introduce Cyclodextrins, concept of Carnitine, veg origin DHA, multi sweeteners concept like Sucralose, Neotame,Acesulfame K, Fructose and Lactitol etc. in India
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag India
Digital Content Digital Content
URL Supplier Web Content
4286-55-9
Salmeterol Xinafoate
Kalintis Healthcare is a vision with a drive to create a health-conscious Pharmaceuticals Company serving...
Kalintis Healthcare is a vision with a drive to create a health-conscious Pharmaceuticals Company serving to bring Wellness to Humanity. We develop robust in-house technology by setting the highest quality standards for the manufacturing of Speciality Chemicals, Advanced Intermediates, and Active Pharmaceutical Ingredients in our Chemical Process R&D and subsequently execute the Commercial-scale manufacturing in order to serve global customers. The APIs manufactured are targeted for the USA market & the rest all products targeted for global supplies. Plans are in place to file atleast three DMF’s in a year.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag India
Digital Content Digital Content
URL Supplier Web Content
163923-18-0
Salmeterol Xinafoate
SLN Pharmachem was setup in 1997 with an objective to provide technology based products (Intermediates) f...
SLN Pharmachem was setup in 1997 with an objective to provide technology based products (Intermediates) for Pharmaceutical, Cosmetic and Fine Chemical Industry. SLN Pharmachem is an ISO certified and has its manufacturing unit backed up by professionals who are desirous in manufacturing new, difficult to produce molecules with success to achieve the best quality standards in the international competition.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag India
Digital Content Digital Content
URL Supplier Web Content
94749-73-2
Salmeterol Xinafoate
SLN Pharmachem was setup in 1997 with an objective to provide technology based products (Intermediates) f...
SLN Pharmachem was setup in 1997 with an objective to provide technology based products (Intermediates) for Pharmaceutical, Cosmetic and Fine Chemical Industry. SLN Pharmachem is an ISO certified and has its manufacturing unit backed up by professionals who are desirous in manufacturing new, difficult to produce molecules with success to achieve the best quality standards in the international competition.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag India
Digital Content Digital Content
URL Supplier Web Content
97664-55-6
Salmeterol Xinafoate
SLN Pharmachem was setup in 1997 with an objective to provide technology based products (Intermediates) f...
SLN Pharmachem was setup in 1997 with an objective to provide technology based products (Intermediates) for Pharmaceutical, Cosmetic and Fine Chemical Industry. SLN Pharmachem is an ISO certified and has its manufacturing unit backed up by professionals who are desirous in manufacturing new, difficult to produce molecules with success to achieve the best quality standards in the international competition.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY